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Abstract
Objectives Guided bone regeneration (GBR) aims to predict-
ably restore missing bone that has been lost due to trauma,
periodontal disease or a variety of systemic conditions.
Critical to this procedure is the ability of a bone grafting ma-
terial to predictably serve as a 3-dimensional scaffold capable
of inducing cell and bone tissue in-growth at the material
surface. Although all bone grafts are osteoconductive to
bone-forming osteoblasts, only a small number of commer-
cially available bone grafts with FDA approval are
osteoinductive including demineralized freeze-dried bone al-
lographs (DFDBA) and scaffolds containing bone morphoge-
netic proteins (BMPs). Recently, a class of synthetic bone
grafts fabricated from biphasic calcium phosphate (BCP)
sintered at a low temperature have been shown to form ectopic
bone formation in non-skeletal sites without the use of growth
factors. Therefore, the present study aimed to compare the
osteoinductive potential of this group of synthetic BCP
alloplasts with autografts, allografts and xenografts.
Materials and methods In the present study, 4 types of bone
grafting materials including autogenous bone harvested with a
bone mill, DFDBA (LifeNet, USA), a xenograft derived from
bovine bone mineral (NBM, BioOss, Geistlich, Switzerland)
and a novel synthetic biphasic calcium phosphate (BCP,
Straumman, Switzerland) were implanted into intramuscular
pouches of 24 rats and analysed histologically for their ability
to form ectopic bone formation around grafting particles. A
semi-quantitative osteoinductive score was used to quantify
the osteoinductive ability of each bone graft.
Results The results from the present study reveal that (1) au-
togenous bone resorbed rapidly in vivo, (2) the xenograft
showed no potential to form ectopic bone formation and (3)
both DFDBA and BCP were able to stimulate ectopic bone
formation.
Conclusion These studies demonstrate that these newly
developed synthetic bone grafts have potential for inducing
ectopic bone formation similar to DFDBA. Future clinical
testing is necessary to reveal their bone-inducing properties
in clinical scenarios including GBR procedures and in combi-
nation with implant dentistry.
Clinical relevance Novel BCP scaffolds are able to induce
ectopic bone formation without the use of osteoinductive
growth factors such as BMP2 and thus demonstrate a large
clinical possibility to further enhance bone formation for a
variety of clinical procedures.
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Introduction
Despite the increasing number of new bone grafting substi-
tutes that have emerged in recent years, to date, there exists no
single ideal replacement grafting material [1]. Autogenous
bone has been considered the golden standard for bone
replacement procedures in dentistry due to its release of
osteogenic growth factors including bone morphogenetic
proteins (BMPs) able to promote the proliferation and dif-
ferentiation of progenitor cells [2, 3]. Furthermore, they
carry no risk of immunologic reaction or disease transmis-
sion and their use provides an optimal environment for
new blood vessel formation [2, 3]. In contrast, many bone
grafting substitutes fabricated from a variety of synthetic
materials such as hydroxyapatite, β-tricalcium phosphate
and bioactive glasses may provide an osteoconductive ma-
trix but without osteoinductive potential [4].
The field of osteoinductive bone grafting materials has
been the cornerstone of much research over the past few de-
cades [5]. Historically, osteoinduction refers to the process by
which one tissue, or product derived from it, causes a second
undifferentiated tissue to differentiate into bone [5]. In 2
classical studies by Marschall Urist in 1965 and 1967,
osteoinduction was defined as Bthe mechanism of cellular dif-
ferentiation towards bone of one tissue due to physicochemi-
cal effect or contact with another tissue^ [6]. In that study, the
ability of an implanted demineralized bone matrix to induce
in-growth ectopic bone formation in connective tissue of rab-
bits, dogs and rats was investigated [7]. Later, a group of low
molecular weight proteins extracted from demineralized bone
matrix (DBM), termed bone morphogenetic proteins (BMPs),
were isolated and characterized showing more osteoinduction
than DBM alone [8]. Despite these early advancements in the
field of osteoinductive biomaterials, to date, only DFDBA and
bone biomaterials containing BMPs are approved by the FDA
as truly osteoinductive materials [5].
Recently, Yuan et al. demonstrated that synthetically fabri-
cated bone grafts sintered at low temperatures possess the
capability of forming ectopic bone formation in large animal
models [9]. Bone defects loaded with these synthetic bone
grafts were also shown to heal as rapidly as autogenous bone
[9]. In light of these recent findings, our group aimed to in-
vestigate the use of this novel synthetic scaffold fabricated
from biphasic calcium phosphate (BCP). BCP bone grafting
particles were compared to 3 commonly employed bone
grafting materials including autogenous bone chips derived
from a bone mill, demineralised freeze-dried bone allografts
(DFDBA) and a commonly employed xenograft (a natural
bone mineral, NBM). The osteoinductive potential of each
bone graft was compared for their ability to induce ectopic




Autogenous bone was harvested from Wistar rats using
cortico-cancellous block grafts harvested with a trephine and
ground to particulated bone chips using a bone mill. The
selection of bone mill as the selection for autogenous bone
harvesting is because it stimulated the highest osteogenic re-
sponse and ability to release growth factors to the surrounding
environment [10, 11].
Allograft bone
Demineralized freeze-dried bone allograft (DFDBA) from
LifeNet (USA) was utilized as the DFDBA of choice due to
previous handling and its ability to form ectopic bone forma-
tion in vivo [12, 13].
Xenograft bone
A natural bone mineral (NBM) of bovine origin (BioOss,
Geistlich, Switzerland) was used as the xenograft of choice
due to its widespread use in dentistry and our laboratories’
previous use in its handling [14–16].
Alloplast bone ceramic
In the present study, a biphasic calcium phosphate (BCP)
was tested. The BCP graft was utilized using a 90:10 ration
of beta-tricalcium phosphate and hydroxyapatite (Vivoss,
Straumann AG, Basel, Switzerland) as previously de-
scribed [17].
Scanning electron microscopy
Bone grafting materials were fixed in 1 % glutaraldehyde and
1 % formaldehyde for 2 days for SEM. Following serial de-
hydration with ethanol, samples were critically point dried
(Type M.9202 Critical Point Dryer, Roth & Co. Hatfield,
PA, USA) followed by overnight drying. The following day,
samples were sputter coated using a Balzers Union Sputtering
Device (DCM-010, Balzers, Liechtenstein) with 10 nm of
gold and analyzed microscopically using a Philips XL30
FEG scanning electron microscope to determine surface var-
iations between bone grafts.
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Animal experiments
Twenty-four male Wistar rats (mean body weight 200 g) were
used with all handling and surgical procedures in accordance
with the policies of the Ethics Committee for Animal
Research at the University of Wuhan, China. Animals were
given food and water ad libitum with constant temperature at
20–25 °C.
All operations were conducted under strictly sterile condi-
tions. For surgery, the rats were generally anesthetized with
intraperitoneal injection of chloral hydrate (10 %, 4 ml/kg
body weight) as previously described [18]. After skin prepa-
ration and disinfection, bilateral muscle pouches were made in
the gastrocnemius muscle of each animal as previously de-
scribed [13]. Subsequently, an equal mass of autogenous bone
(20 mg per pouch), DFDBA particles (20 mg per pouch),
NBM (20 mg per pouch) and BCP (20 mg per pouch) were
implanted intramuscularly and incisions were sutured in two
layers. Postoperatively, penicillin (400,000 IU/ml, 0.1 ml/kg)
was injected for 3 days. After 3 and 6 weeks postimplantation,
rats were sacrificed and samples were removed and prepared
for histological analysis.
Histological analysis
The samples were decalcified in 10 % EDTA replaced twice
weekly for 3 weeks at room temperature. Samples were then
dehydrated in a series of graded concentrations of ethanol
from 30 to 100 % followed by embedding in paraffin as pre-
viously described [19]. Serial sections of 5 μm were cut and
mounted on polylysine-coated microscope slides and stained
with H&E (Sigma #S2255; Sigma-Aldrich, St. Louis, USA)
in accordance with the manufacturer’s protocol and also as
previously described to visualize ectopic bone formation. All
samples were observed for evidence of ectopic bone forma-
tion and remaining bone grafting particles. Furthermore, the
ability of the samples to induce new ectopic bone formation
was semi-qualitatively evaluated by two independent ob-
servers (QZ, YZ) blinded to treatment and rated according to
a previously published scheme [20–24]. Three consecutive
sections (3 to 4 μm each) were obtained at 3 different levels
throughout the block along the longitudinal axis for evalua-
tion. The ability of the samples to induce new bone was qual-
itatively evaluated by the 2 independent observers and rated
accordingly as described below. In total, 4 separate fields in
Fig. 1 SEM images of
autogenous bone harvested via
bone milling a, b, an allograft
(DFDBA) c, d and a xenograft
(NBM) e, f at low a, c, e and high
b, d, f magnification
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each of the 3 different sections were evaluated for ectopic
bone formation according to the following score: A score
of 1 indicated the presence of particles without any bone;
2 indicated the production of a new bone in one site
within the section and covering less than 40 % of the
surface area examined; 3 indicated the production of a
new bone in more than one site, covering more than
40 % but less than 70 %, of the surface area examined;
and 4 indicated the production of a new bone in more
than one site, covering more than 70 % of the surface
area examined. The overall grade for each implant was




SEM was utilized to visualize bone grafting particles
both at low and high magnification (Figs. 1 and 2).
Autogenous bone chips derived from a bone mill
showed various shapes and sizes from 0.1 mm to slight-
ly greater than 1 mm (Fig. 1a). The high-resolution
magnification demonstrated a number of proteins re-
maining on the particle surface with a number of cells
still present on its surface following sample harvesting
(Fig. 1b). On the other hand, DFDBA particles were
slightly smaller in size with particle surface devoid of
any visible proteins and with a very smooth surface
(Fig. 1c, d). Xenograft particles were also very similar
in size to DFDBA ranging from 0.3 to approximately
1 mm (Fig. 1e). Interestingly, the material surface had
quite a roughened surface when compared to either au-
togenous bone or the alloplast (Fig. 1f). The material
surface was completely devoid of all proteins (Fig. 1f).
Following analysis of 3 commonly used bone grafting
materials, BCP grafts were visualized (Fig. 2). As can be
depicted from the SEM images at a low magnification, the
new synthetic bone grafts present with many macro-
topographies (Fig. 2a). Furthermore, the high-resolution
SEM images demonstrate extremely roughened surfaces
(Fig. 2c).
Ectopic bone formation
Following SEM analysis, ectopic bone formation was in-
vestigated for all bone grafting particles at 3 and 6 weeks
postimplantation (Fig. 3). Interestingly, autogenous bone
demonstrated some signs of ectopic bone formation at 3 weeks
(Fig. 3a, arrow). By 6 weeks, the bone graft was entirely
resorbed and muscle was found surrounding the original de-
fect site (Fig. 3b). NBM derived from bovine origin
demonstrated no signs of ectopic bone formation either at 3
or 6 weeks (Fig. 3c). Following 6 weeks, the xenograft mate-
rial was still present in muscle pouches with a large number of
infiltration inflammatory monocytes found within connective
tissues surrounding the bone particles (Fig. 3c). The implan-
tation of DFDBA to the muscle pouches demonstrated signs
of ectopic bone formation at both time points (Fig. 3e, f).
Results varied between the 6 animals tested, largely dependant
Fig. 2 SEM images of novel BCP bone grafting material demonstrating
many macro- and nano-topographies at low a, moderate b and high c
magnification
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on the batch of DFDBA chosen; however, most of the new
bone formation was found adjacent to the scaffold surface
(Fig. 3e, f, arrows). Interestingly, the BCP group with a high
macro- and microtopographies (Fig. 2) was able to form ec-
topic bone formation as depicted in Fig. 3g, h. Ectopic bone
formation was found in all samples adjacent to the bone
grafting particle surface at 3 weeks with an additional bone
being formed by 6 weeks (Fig. 3h). All samples were quanti-
fied using a semi-quantitative osteoinduction score (Fig. 4).
By 6 weeks, all autografts were resorbed with some signs of
osteoinduction visible at 3 weeks. The NBM had no ability to
form ectopic bone formation and remained present at 6 weeks
(Fig. 4). Both DFDBA and BCP demonstrated the ability to
form ectopic bone formation. More variability was found for
DFDBA samples (Fig. 4).
Discussion
The aim of the present study was to test the osteoinductive
potential of 4 bone grafting materials commonly utilized in
the field of implant dentistry. There exists a large variabil-
ity between the bone-forming capabilities of various bone
grafts, and the osteoinductive potential remains one of the
key features to improve the integration of implanted bone
grafts [5]. While the field of implant dentistry has made a
number of significant advances in recent years, the use of
an autogenous bone has remained the gold standard for
bone grafting procedures over the past several decades.
Despite this, numerable attempts have been made to sub-
stitute autogenous bone grafts with other replacement op-
tions due to their drawbacks that include increased patient
morbidity, limited availability and extra surgical
time/costs.
Therefore, the present study investigated a newly devel-
oped synthetic bone graft fabricated from a biphasic calcium
phosphate fabricated from 10:90 ratio of hydroxyapatite and
β-tricalcium phosphate (Fig. 2). These novel grafts show
promising features as a bone grafting material by
demonstrating extremely highmacro- and nanoporosities, ide-
al characteristics for bone growth [25–27] capable of forming
ectopic bone formation (Fig. 3). Previously, Dahlin et al. com-
pared these same BCP bone grafts with a 2nd BCP-II grafting
material composed of 60 % hydroxyapatite/40 % β-TCP, as
well as a NBM in surgically created defects in the mandible of
minipigs [28]. It was found that BCP-I showed significant
higher amounts of newly formed bone when compared to
the other 2 groups including the NBM utilized in our study
[28]. Therefore, consistent with those results, the
osteoinductive model utilized in the present study demonstrat-
ed similar in vivo characteristics on new bone formation as
presented previously by Dahlin et al. [28].
Not surprisingly, the natural bone mineral derived from
bovine origin was unable to show signs of ectopic bone for-
mation. These bone grafts have been used extensively in bone
grafting procedures over the years due to their ability to re-
main present with little to no evidence of bone resorption even
years after implantation [29–31]. While these grafts demon-
strated numerous clinical advantages, there drawbacks include
no osteoinductive potential limiting their ability to rapidly
stimulate new bone formation. Previously, Donos et al. further
Fig. 3 H&E staining of bone
grafts (BG) tested for ectopic
bone formation in the
gastrocnemius muscle of rats at 3
and 6 weeks postimplantation.
(Bar = 500 μm; BG = bone graft,
CT = connective tissue,
Mu = muscle; arrows indicate
new ectopic bone formation)
Fig. 4 The effect of different bone grafts on osteoinductivity using a
qualitative scoring system: 0 = no evidence of any bone graft, 1 = only
original bone graft present, 2 = one site with visible ectopic bone
formation, 3 = two or more sites of ectopic bone formation, 4 = >70 %
of field at ×10 covered by a new bone (*p < 0.05, #p < 0.05; group lower
than all other groups)
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showed that these xenografts were also incapable of forming
ectopic bone formation [32], consistent with the results found
in our study.
It was also noted in the present study that the allografts
demonstrated selective ability to form ectopic bone formation
with variable rates of bone around the implanted grafts. It has
previously been reported that DFDBA has variable rates of
bone formation largely dependent on donor age, medical con-
dition as well as sterilization procedures [13, 33]. Thus, while
the ability for DFDBA to form ectopic bone formation was
confirmed in the present study, one of the advantages of using
a synthetic material could more predictably produce new bone
formation when compared to DFDBA from various donor
batches.
One of the key remaining questions presently investi-
gated by our group is to determine the mechanism by
which these novel BCP bone grafting materials are able
to direct and induce ectopic bone formation. Recent studies
have begun to implicate immune cells as the possible
governing cells responsible for dictating new bone forma-
tion around certain classes of bone biomaterials [34–36]. A
special subset of macrophages (osteal macrophages, also
referred to as OsteoMacs) is currently being investigated
as possible key players responsible for guiding new bone
formation around these bone biomaterials [37]. While lim-
ited available data still exists in the literature, future strat-
egies to further characterize these cells within osteal tissues
as well as their plausible roles in bone induction of bioma-
terials remains necessary.
In conclusion, the results from the present study demon-
strate that these novel BCP scaffolds possess an
osteoinductive potential by demonstrating ectopic bone for-
mation in skeletal sites in a rat muscle.While autogenous bone
is still considered the gold standard of bone grafting materials
due to its excellent combination of osteogenesis,
osteoinduction and osteoconduction, novel synthetic materials
are slowly paving a path which may demonstrate equivalent
bone-forming abilities in the near future.
Compliance with ethical standards
Conflict of interest BCP grafts were kindly provided by Straumann
AG, Switzerland. Benjamin Pippenger and Michel Dard are both em-
ployees of Straumann AG who contributed to the experimental design
and provided the bone grafting materials. All other authors declare no
conflict of interest.
Funding This study was supported by a grant from the American
Academy of Implant Dentistry to Richard J. Miron (2013).
Ethical approval All applicable international, national and/or institu-
tional guidelines for the care and use of animals were followed by the
University of Wuhan, Department of Oral Implantology, China.
Informed consent No informed patient consent was necessary.
References
1. Jensen SS, Bornstein MM, DardM, Bosshardt DD, Buser D (2009)
Comparative study of biphasic calcium phosphates with different
HA/TCP ratios in mandibular bone defects. A long-term
histomorphometric study in minipigs. J Biomed Mater Res B
Appl Biomater 90:171–181. doi:10.1002/jbm.b.31271
2. Mazock JB, Schow SR, Triplett RG (2004) Proximal tibia bone
harvest: review of technique, complications, and use in maxillofa-
cial surgery. Int J Oral Maxillofac Implants 19:586–593
3. Jakse N, Seibert FJ, Lorenzoni M, Eskici A, Pertl C (2001) A
modified technique of harvesting tibial cancellous bone and its
use for sinus grafting. Clin Oral Implants Res 12:488–494
4. Giannoudis PV, Dinopoulos H, Tsiridis E (2005) Bone substitutes:
an update. Injury 36(Suppl 3):S20–S27. doi:10.1016/j.injury.2005.
07.029
5. Miron RJ, Zhang YF (2012) Osteoinduction: a review of old con-
cepts with new standards. J Dent Res 91:736–744. doi:10.1177/
0022034511435260
6. Urist MR, Silverman BF, Buring K, Dubuc FL, Rosenberg JM
(1967) The bone induction principle. Clin Orthop Relat Res 53:
243–283
7. Urist MR (1965) Bone: formation by autoinduction. Sci (New
York, NY) 150:893–899
8. Urist MR, Strates BS (1971) Bone morphogenetic protein. J Dent
Res 50:1392–1406
9. Yuan H, Fernandes H, Habibovic P, de Boer J, Barradas AM, de
Ruiter A, Walsh WR, van Blitterswijk CA, de Bruijn JD (2010)
Osteoinductive ceramics as a synthetic alternative to autologous
bone grafting. Proc Natl Acad Sci U S A 107:13614–13619. doi:
10.1073/pnas.1003600107
10. Miron RJ, Gruber R, Hedbom E, Saulacic N, Zhang Y, Sculean A,
Bosshardt DD, Buser D (2012) Impact of bone harvesting tech-
niques on cell viability and the release of growth factors of auto-
grafts. Clin Implant Dent Relat Res. doi:10.1111/j.1708-8208.2012.
00440.x
11. Miron RJ, Hedbom E, Saulacic N, Zhang Y, Sculean A, Bosshardt
DD, Buser D (2011) Osteogenic potential of autogenous bone grafts
harvested with four different surgical techniques. J Dent Res 90:
1428–1433. doi:10.1177/0022034511422718
12. Miron RJ, Bosshardt DD, Laugisch O, Dard M, Gemperli AC,
Buser D, Gruber R, Sculean A (2013) In vitro evaluation of
demineralized freeze-dried bone allograft in combination with
enamel matrix derivative. J Periodontol 84:1646–1654. doi:10.
1902/jop.2013.120574
13. Wei L, Miron RJ, Shi B, Zhang Y (2013) Osteoinductive and
osteopromotive variability among different demineralized bone al-
lografts. Clin Implant Dent Relat Res. doi:10.1111/cid.12118
14. Miron RJ, Bosshardt DD, Laugisch O, Katsaros C, Buser D,
SculeanA (2012) Enamel matrix protein adsorption to root surfaces
in the presence or absence of human blood. J Periodontol 83:885–
892. doi:10.1902/jop.2011.110404
15. Miron RJ, Bosshardt DD, Zhang Y, Buser D, Sculean A (2012)
Gene array of primary human osteoblasts exposed to enamel matrix
derivative in combination with a natural bone mineral. Clin Oral
Investig. doi:10.1007/s00784-012-0742-0
16. Miron RJ, Wei L, Bosshardt DD, Buser D, Sculean A, Zhang Y
(2014) Effects of enamel matrix proteins in combination with a
bovine-derived natural bone mineral for the repair of bone defects.
Clin Oral Investig 18:471–478. doi:10.1007/s00784-013-0992-5
17. Miron RJ, Bosshardt DD, Gemperli AC, Dard M, Buser D, Gruber
R, Sculean A (2014) In vitro characterization of a synthetic calcium
phosphate bone graft on periodontal ligament cell and osteoblast
behavior and its combinationwith an enamel matrix derivative. Clin
Oral Investig 18:443–451. doi:10.1007/s00784-013-0977-4
2264 Clin Oral Invest (2016) 20:2259–2265
18. Zhang Y, Wei L, Miron RJ, Shi B, Bian Z (2015) Anabolic bone
formation via a site-specific bone-targeting delivery system by in-
terfering with semaphorin 4d expression. J Bone Miner Res Off J
Am Soc Bone Miner Res 30:286–296. doi:10.1002/jbmr.2322
19. Zhang Y, Wu C, Luo T, Li S, Cheng X, Miron RJ (2012) Synthesis
and inflammatory response of a novel silk fibroin scaffold contain-
ing BMP7 adenovirus for bone regeneration. Bone 51:704–713.
doi:10.1016/j.bone.2012.06.029
20. Ranly DM, Lohmann CH, Andreacchio D, Boyan BD, Schwartz Z
(2007) Platelet-rich plasma inhibits demineralized bone matrix-
induced bone formation in nude mice. J Bone Joint Surg Am 89:
139–147. doi:10.2106/jbjs.f.00388
21. Schwartz Z, Mellonig JT, Carnes Jr DL, de la Fontaine J, Cochran
DL, Dean DD, Boyan BD (1996) Ability of commercial
demineralized freeze-dried bone allograft to induce new bone for-
mation. J Periodontol 67:918–926. doi:10.1902/jop.1996.67.9.918
22. Schwartz Z, Weesner T, van Dijk S, Cochran DL, Mellonig JT,
Lohmann CH, Carnes DL, Goldstein M, Dean DD, Boyan BD
(2000) Ability of deproteinized cancellous bovine bone to induce
new bone formation. J Periodontol 71:1258–1269. doi:10.1902/jop.
2000.71.8.1258
23. Miron RJ, Sculean A, Shuang Y, Bosshardt DD, Gruber R, Buser
D, Chandad F, Zhang Y (2015) Osteoinductive potential of a novel
biphasic calcium phosphate bone graft in comparison with auto-
graphs, xenografts, and DFDBA. Clin Oral Implants Res. doi:10.
1111/clr.12647
24. Wei L, Miron RJ, Shi B, Zhang Y (2015) Osteoinductive and
osteopromotive variability among different demineralized bone al-
lografts. Clin Implant Dent Relat Res 17:533–542. doi:10.1111/cid.
12118
25. Chan O, Coathup MJ, Nesbitt A, Ho CY, Hing KA, Buckland T,
Campion C, Blunn GW (2012) The effects of microporosity on
osteoinduction of calcium phosphate bone graft substitute biomate-
rials. Acta Biomater 8:2788–2794. doi:10.1016/j.actbio.2012.03.
038
26. Coathup MJ, Hing KA, Samizadeh S, Chan O, Fang YS, Campion
C, Buckland T, Blunn GW (2012) Effect of increased strut porosity
of calcium phosphate bone graft substitute biomaterials on
osteoinduction. J Biomed Mater Res A 100:1550–1555. doi:10.
1002/jbm.a.34094
27. Habibovic P, Gbureck U, Doillon CJ, Bassett DC, van Blitterswijk
CA, Barralet JE (2008) Osteoconduction and osteoinduction of
low-temperature 3D printed bioceramic implants. Biomaterials 29:
944–953. doi:10.1016/j.biomaterials.2007.10.023
28. Dahlin C, ObrechtM, DardM, Donos N (2015) Bone tissue model-
ling and remodelling following guided bone regeneration in
combination with biphasic calcium phosphate materials presenting
different microporosity. Clin Oral Implants Res 26:814–822. doi:
10.1111/clr.12361
29. Bornstein MM, Chappuis V, von Arx T, Buser D (2008)
Performance of dental implants after staged sinus floor elevation
procedures: 5-year results of a prospective study in partially eden-
tulous patients. Clin Oral Implants Res 19:1034–1043. doi:10.
1111/j.1600-0501.2008.01573.x
30. Jensen SS, Aaboe M, Janner SF, Saulacic N, Bornstein MM,
Bosshardt DD, Buser D (2013) Influence of particle size of
deproteinized bovine bone mineral on new bone formation and
implant stability after simultaneous sinus floor elevation: a
histomorphometric study in minipigs. Clin Oral Implants Res.
doi:10.1111/cid.12101
31. Jensen SS, Bosshardt DD, Gruber R and Buser D (2014) Long-term
stability of contour augmentation in the esthetic zone. Histologic
and histomorphometric evaluation of 12 human biopsies 14 to 80
months after augmentation. J Periodontol:1–15. doi:10.1902/jop.
2014.140182
32. Donos N, Kostopoulos L, Tonetti M, Karring T, Lang NP (2006)
The effect of enamel matrix proteins and deproteinized bovine bone
mineral on heterotopic bone formation. Clin Oral Implants Res 17:
434–438. doi:10.1111/j.1600-0501.2006.01260.x
33. Schwartz Z, Somers A, Mellonig JT, Carnes Jr DL, Dean DD,
Cochran DL, Boyan BD (1998) Ability of commercial
demineralized freeze-dried bone allograft to induce new bone for-
mation is dependent on donor age but not gender. J Periodontol 69:
470–478. doi:10.1902/jop.1998.69.4.470
34. Davison NL, Gamblin AL, Layrolle P, Yuan H, de Bruijn JD,
Barrere-de Groot F (2014) Liposomal clodronate inhibition of os-
teoclastogenesis and osteoinduction by submicrostructured beta-
tricalcium phosphate. Biomaterials 35:5088–5097. doi:10.1016/j.
biomaterials.2014.03.013
35. Davison NL, Su J, Yuan H, van den Beucken JJ, de Bruijn JD,
Barrere-de Groot F (2015) Influence of surface microstructure and
chemistry on osteoinduction and osteoclastogenesis by biphasic
calcium phosphate discs. Eur Cell Mater 29:314–329
36. Davison NL, ten Harkel B, Schoenmaker T, Luo X, Yuan H, Everts
V, Barrere-de Groot F, de Bruijn JD (2014) Osteoclast resorption of
beta-tricalcium phosphate controlled by surface architecture.
Biomaterials 35:7441–7451. doi:10.1016/j.biomaterials.2014.05.
048
37. Miron RJ, Bosshardt DD (2016) OsteoMacs: key players around
bone biomaterials. Biomaterials 82:1–19. doi:10.1016/j.
biomaterials.2015.12.017
Clin Oral Invest (2016) 20:2259–2265 2265
